Prepare yourself for the winter season with the Core tests® ComboResp.
Qualitative and differential detection of nucleocapsid protein antigen from Influenza A (including the subtype H1N1), Influenza B, RSV and/or Covid-19 in nasal swab specimens from symptomatic and asymptomatic patients. Aids in the rapid diagnosis of Influenza A, Influenza B, Respiratory Syncytial Virus, and/or SARS-CoV-2 infections in the healthcare setting management, general population screening, workplace screening, etc. Intended for professional use.
Key Features
- Rapid - Results in just 10 minutes
- Reliable - CTDA Approved and CE-IVD Marked
- Convenient - 1 Swab, 1 test Card, 4 Results
Diagnostic Sensitivity and Specificity
- Influenza A: Sensitivity of 99.2% (118/119), Specificity of 99.6% (479/481), Total Agreement of 99.5% (597/600).
- Influenza B: Sensitivity of 99.1% (109/110), Specificity of 99.8% (489/490), Total Agreement of 99.7% (598/600).
- Covid-19: Sensitivity of 70.91% (78/110), Specificity: 100.00% (150/150), Total Agreement: of 87.69% (228/260)
- RSV: Sensitivity of 97.4% (112/115), Specificity of 99.3% (298/300), Total Agreement of 98.8% (410/415)
Downloads
Disclaimer - This product is licensed for professional use only.
